Xenetic Biosciences Inc.

XBIO | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.61

-$0.38 (-12.71%)

Sep 22, 2026, 12:35 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $6.85M

Enterprise Value $378.49K

Beta 2.24

Average Volume 31.91K

Shares Outstanding (Diluted) 2.29M

Shares Change YoY 48.78%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US9840156023

Price Performance

Price Change 1M -20.1%

Price Change 3M 3.1%

Price Change 6M 0.0%

Price Change YTD 39.1%

Price Change 1Y -4.2%

Price Change 3Y -47.4%

Price Change 5Y -86.5%

1M CAGR (ann.) -5.7%

1Y CAGR (ann.) -4.2%

5Y CAGR (ann.) -35.3%

All-Time CAGR -40.5%

Valuation

PE Ratio -2.51

Forward PE N/A

PEG Ratio -0.05

Forward PEG 0.03

PS Ratio 2.10

Forward PS 2.70

PB Ratio 1.13

P/FCF Ratio -2.96

P/Adj. FCF Ratio -2.87

P/OCF Ratio -2.96

EV/Sales 0.12

EV/EBIT -0.24

EV/EBITDA -0.15

EV/FCF -0.16

Earnings Yield -39.8%

FCF Yield -33.8%

Adj. FCF Yield -34.9%

Financial Health

Net Cash $6.47M

Total Debt $0

Cash & Short-Term Investments $6.47M

Total Assets $6.97M

Current Ratio 7.43

Quick Ratio 7.43

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -35.12

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 100.0%

Operating Profit Margin -81.0%

EBITDA Margin -75.9%

Net Profit Margin -75.9%

FCF Margin -70.9%

Adj. FCF Margin -73.3%

SBC / Revenue 2.0%

SBC Impact (per share) -3.3%

Returns

Return on Assets -35.5%

Return on Equity -40.6%

Return on Invested Capital -43.5%

Return on Capital Employed -43.5%

Return on Tangible Assets -35.5%

Historical Growth (CAGR)

Revenue CAGR 3Y 14.8%

Revenue CAGR 5Y 34.3%

Revenue CAGR 10Y -3.7%

EPS CAGR 3Y 44.9%

EPS CAGR 5Y 36.3%

EPS CAGR 10Y 35.8%

FCF CAGR 3Y 20.2%

FCF CAGR 5Y 21.6%

FCF CAGR 10Y 6.6%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 5, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-2.31M

Free Cash Flow $-2.31M

Adj. Free Cash Flow $-2.39M

FCF Per Share -$1.01

OCF Per Share -$1.01

OCF/S Ratio -70.9%

Income Statement

Revenue $3.26M

Gross Profit $2.6M

Operating Income $-2.64M

EBITDA $-2.52M

Net Income $-2.48M

EPS (Diluted) -$1.19

Revenue / Employee $1.63M

Profit / Employee $-1.24M

Employees 2